The risk of systemic toxicity with microneedles is generally lower compared to traditional methods of drug delivery, such as oral or intravenous routes. This is because microneedles can deliver drugs directly to the targeted site, reducing the overall drug dosage needed. However, it is crucial to evaluate the pharmacokinetics and pharmacodynamics of the drug in question to ensure that it does not accumulate to toxic levels in the body.
